自1980年Lebrec首次报道心得安降低门脉高压以来,β—阻滞剂用于预防肝硬化上消化道出血复发,引起不少学者的关注,现将这方面的资料综述如下: 一、降低门脉高压:1980年Lebrec研究了16例肝硬化患者,均因食道静脉曲张破裂出血入院,出血部位经急诊内窥镜证实,肝硬化经组织学证实。将16例分为两 Since Lebrec was first reported in 1980, lowering the portal hypertension, β-blockers have been used to prevent the recurrence of upper gastrointestinal bleeding in cirrhosis and aroused the concern of many scholars. The data in this respect are summarized as follows: Pulmonary Hypertension: In 1980, Lebrec studied 16 patients with cirrhosis who were all admitted to hospital due to esophageal variceal bleeding. The bleeding site was confirmed by emergency endoscopy and cirrhosis was confirmed by histology. Divide 16 into two